HilaryGomolinMD

Hematologic Oncology

Medical Oncology-Hematology | Lynn Cancer Institute | Baptist Health South Florida

Dr. Gomolin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6282 Linton Blvd
Delray Beach, FL 33484
Phone+1 561-495-8307

Fax+1 561-495-6422

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
McGill University Faculty of MedicineClass of 1986

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

PubMed

98 citations
Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck
A. D. Colevas, C. M. Norris, Roy B. Tishler, M. P. Fried, H. I. Gomolin
Journal of Clinical Oncology. 1999-11-01
13 citations
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.
A. Dimitrios Colevas, Philip C. Amrein, Hilary Gomolin, J B S Jennifer Barton, R. Read
Cancer. 2001-07-15
41 citations
Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy.
David Goltzman, Hilary Gomolin, André Delean, Marvin J. Wexler, Jonathan L. Meakins
The Journal of Clinical Endocrinology and Metabolism. 1984-01-01

Could Fruit Flies Help Match Patients with Cancer Treatments?February 26th, 2021